{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:23:01Z","timestamp":1793982181792,"version":"4.8.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.1001\/jamacardio.2022.1061","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T15:06:30Z","timestamp":1652886390000},"page":"715","source":"Crossref","is-referenced-by-count":86,"title":["Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank"],"prefix":"10.1001","volume":"7","author":[{"given":"Kiran J.","family":"Biddinger","sequence":"first","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Princeton University, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Jurgens","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Experimental Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Maamari","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Gaziano","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoan","family":"Choi","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie N.","family":"Morrill","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Halford","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Khera","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Lubitz","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Ellinor","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna G.","family":"Aragam","sequence":"additional","affiliation":[{"name":"Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts"},{"name":"Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"hoi220019r1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity.","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"issue":"19","key":"hoi220019r2","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry.","volume":"74","author":"Neubauer","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi220019r3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41436-018-0375-z","article-title":"Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield.","volume":"21","author":"Thomson","year":"2019","journal-title":"Genet Med"},{"issue":"11","key":"hoi220019r4","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"issue":"2","key":"hoi220019r5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"issue":"11","key":"hoi220019r6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy.","volume":"78","author":"de Marvao","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"hoi220019r7","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1161\/CIR.0000000000000937","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"hoi220019r11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41436-018-0039-z","article-title":"Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).","volume":"20","author":"Hershberger","year":"2018","journal-title":"Genet Med"},{"issue":"8","key":"hoi220019r12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015473","article-title":"Contemporary insights into the genetics of hypertrophic cardiomyopathy: toward a new era in clinical testing?","volume":"9","author":"Mazzarotto","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"hoi220019r13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat Genet"},{"issue":"7726","key":"hoi220019r14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data.","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"7","key":"hoi220019r15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41588-021-00885-0","article-title":"Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank.","volume":"53","author":"Szustakowski","year":"2021","journal-title":"Nat Genet"},{"issue":"3","key":"hoi220019r16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41588-021-01011-w","article-title":"Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank.","volume":"54","author":"Jurgens","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"hoi220019r17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm6010002","article-title":"Building the Partners HealthCare Biobank at Partners Personalized Medicine: informed consent, return of research results, recruitment lessons and operational considerations.","volume":"6","author":"Karlson","year":"2016","journal-title":"J Pers Med"},{"issue":"18","key":"hoi220019r18","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults.","volume":"358","author":"Morita","year":"2008","journal-title":"N Engl J Med"},{"issue":"24","key":"hoi220019r19","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1002\/sim.v25:24","article-title":"A comparative investigation of methods for logistic regression with separated or nearly separated data.","volume":"25","author":"Heinze","year":"2006","journal-title":"Stat Med"},{"issue":"11","key":"hoi220019r20","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1161\/ATVBAHA.120.314856","article-title":"Genome-wide polygenic score, clinical risk factors, and long-term trajectories of coronary artery disease.","volume":"40","author":"Hindy","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"hoi220019r21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/CIRCRESAHA.119.315686","article-title":"Monogenic and polygenic contributions to atrial fibrillation risk: results from a national biobank.","volume":"126","author":"Choi","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"hoi220019r22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/ped.1996.38.issue-1","article-title":"Hypertrophic cardiomyopathy in Noonan syndrome.","volume":"38","author":"Nishikawa","year":"1996","journal-title":"Acta Paediatr Jpn"},{"issue":"32","key":"hoi220019r23","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/eurheartj\/ehab424","article-title":"Alpha-protein kinase 3 (ALPK3)-truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.","volume":"42","author":"Lopes","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"hoi220019r24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003127","article-title":"A pathogenic variant in ALPK3 is associated with an autosomal dominant adult-onset hypertrophic cardiomyopathy.","volume":"13","author":"Cheawsamoot","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"25","key":"hoi220019r25","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1161\/CIRCULATIONAHA.121.053527","article-title":"Time to think differently about sarcomere-negative hypertrophic cardiomyopathy.","volume":"143","author":"Watkins","year":"2021","journal-title":"Circulation"},{"issue":"10253","key":"hoi220019r26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"hoi220019r27","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41591-021-01505-4","article-title":"Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial.","volume":"27","author":"Ho","year":"2021","journal-title":"Nat Med"},{"key":"hoi220019r28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/CLEP","article-title":"Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes.","volume":"9","author":"Magnusson","year":"2017","journal-title":"Clin Epidemiol"},{"key":"hoi220019r29","doi-asserted-by":"publisher","first-page":"m131","DOI":"10.1136\/bmj.m131","article-title":"Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis.","volume":"368","author":"Batty","year":"2020","journal-title":"BMJ"},{"issue":"25","key":"hoi220019r30","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy.","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"hoi220019r8","unstructured":"Invitae. Invitae hypertrophic cardiomyopathy panel. Accessed April 7, 2021. https:\/\/www.invitae.com\/en\/physician\/tests\/02261\/"},{"key":"hoi220019r9","unstructured":"Blueprint Genetics. Genetic testing for hypertrophic cardiomyopathy. Accessed April 7, 2021. https:\/\/blueprintgenetics.com\/tests\/panels\/cardiology\/hypertrophic-cardiomyopathy-hcm-panel\/"},{"key":"hoi220019r10","unstructured":"GeneDx. Hypertrophic cardiomyopathy (HCM) panel. Accessed April 7, 2021. https:\/\/www.genedx.com\/tests\/detail\/hypertrophic-cardiomyopathy-hcm-panel-863"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2792281\/jamacardiology_biddinger_2022_oi_220019_1656698816.94773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T16:27:53Z","timestamp":1657729673000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2792281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2022.1061","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}